IL-4-induced selective clearance of oligomeric β-amyloid peptide 1-42 by rat primary type 2 microglia

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6503-6513

  Shimizu, Eisuke ^a   Kawahara, Kohichi ^a   Kajizono, Makoto ^a   Sawada, Makoto ^b   Nakayama, Hitoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CD36 ANTIGEN; INSULIN; INSULINASE; INTERLEUKIN 13; INTERLEUKIN 4; IODINE 125; MEMBRANE METALLOENDOPEPTIDASE; SCAVENGER RECEPTOR; THIORPHAN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); CD36L2 PROTEIN, RAT; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CHO CELL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WESTERN BLOTTING; WISTAR KYOTO RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CLASSIFICATION; CRICETULUS; DIMERIZATION; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HAMSTER; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; UPREGULATION; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS, CD36; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; DIMERIZATION; HUMANS; INSULYSIN; INTERLEUKIN-4; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MICE; MICROGLIA; NEPRILYSIN; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, SCAVENGER; UP-REGULATION;

EID: 58749093072     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6503     Document Type: Article

References (62)

1. Hardy, J., and D. J. Selkoe. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. (Pubitemid 34790756)
2. Kayed, R., E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, and C. G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489. (Pubitemid 36444329)
3. Hoshi, M., M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, N. Yoshida, and K. Sato. 2003. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate τ protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. USA 100: 6370-6375. (Pubitemid 36666588)
4. McGeer, P. L., and E. G. McGeer. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21: 195-218.
5. Gonzalez-Scarano, F., and G. Baltuch. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22: 219-240. (Pubitemid 29144887)
6. Meda, L., M. A. Cassatella, G. I. Szendrei, L. Otvos, Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rossi. 1995. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374: 647-650.
7. Demuro, A., E. Mina, R. Kayed, S. C. Milton, I. Parker, and C. G. Glabe. 2005. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280: 17294-17300. (Pubitemid 41389198)
8. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691. (Pubitemid 26282167)
9. Lue, L. F., D. G. Walker, L. Brachova, T. G. Beach, J. Rogers, A. M. Schmidt, D. M. Stern, and S. D. Yan. 2001. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171: 29-45.
10. Huang, F., M. Buttini, T. Wyss-Coray, L. McConlogue, T. Kodama, R. E. Pitas, and L. Mucke. 1999. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors. Am. J. Pathol. 155: 1741-1747.
11. Chung, H., M. I. Brazil, T. T. Soe, and F. R. Maxfield. 1999. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells. J. Biol. Chem. 274: 32301-32308. (Pubitemid 129503830)
12. Wyss-Coray, T., E. Masliah, M. Mallory, L. McConlogue, K. Johnson-Wood, C. Lin, and L. Mucke. 1997. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 389: 603-606. (Pubitemid 27446177)
13. Weiner, H. L., and D. Frenkel. 2006. Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 6: 404-416.
14. Schenk, D., R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, et al. 1999. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400: 173-177. (Pubitemid 29327547)
15. Bard, F., C. Cannon, R. Barbour, R. L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, et al. 2000. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6: 916-919. (Pubitemid 30644751)
16. +PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels. DNA Cell Biol. 20: 731-736.
17. El Khoury, J., M. Toft, S. E. Hickman, T. K. Means, K. Terada, C. Geula, and A. D. Luster. 2007. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13: 432-438. (Pubitemid 46559828)
18. Simard, A. R., D. Soulet, G. Gowing, J. P. Julien, and S. Rivest. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49: 489-502.
19. Mitrasinovic, O. M., and G. M. Murphy, Jr. 2003. Microglial overexpression of the M-CSF receptor augments phagocytosis of opsonized Aβ. Neurobiol. Aging 24: 807-815.
20. Harris-White, M. E., and S. A. Frautschy. 2005. Low density lipoprotein receptor- related proteins (LRPs), Alzheimer's and cognition. Curr. Drug Targets CNS Neurol. Disord. 4: 469-480. (Pubitemid 41448375)
21. Hammad, S. M., S. Ranganathan, E. Loukinova, W. O. Twal, and W. S. Argraves. 1997. Interaction of apolipoprotein J-amyloid β-peptide complex with low density lipoprotein receptor-related protein-2/megalin: a mechanism to prevent pathological accumulation of amyloid β-peptide. J. Biol. Chem. 272: 18644-18649.
22. Carro, E., J. L. Trejo, T. Gomez-Isla, D. LeRoith, and I. Torres-Aleman. 2002. Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat. Med. 8: 1390-1397. (Pubitemid 36019424)
23. 1-42-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 113: 49-62.
24. Goerdt, S., and C. E. Orfanos. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142. (Pubitemid 29115619)
25. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555. (Pubitemid 35223554)
26. Duffield, J. S. 2003. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. Lond. 104: 27-38.
27. Koenigsknecht-Talboo, J., and G. E. Landreth. 2005. Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proin- flammatory cytokines. J. Neurosci. 25: 8240-8249. (Pubitemid 41292118)
28. Kanzawa, T., M. Sawada, K. Kato, K. Yamamoto, H. Mori, and R. Tanaka. 2000. Differentiated regulation of allo-antigen presentation by different types of murine microglial cell lines. J. Neurosci. Res. 62: 383-388. (Pubitemid 30822720)
29. Tomokiyo, R., K. Jinnouchi, M. Honda, Y. Wada, N. Hanada, T. Hiraoka, H. Suzuki, T. Kodama, K. Takahashi, and M. Takeya. 2002. Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 161: 123-132. (Pubitemid 34214828)
30. Dahlgren, K. N., A. M. Manelli, W. B. Stine, Jr., L. K. Baker, G. A. Krafft, and M. J. LaDu. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277: 32046-32053.
31. Suzumura, A., S. G. Mezitis, N. K. Gonatas, and D. H. Silberberg. 1987. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by γ-interferon. J. Neuroimmunol. 15: 263-278. (Pubitemid 17108036)
32. Sawada, M., A. Suzumura, H. Yamamoto, and T. Marunouchi. 1990. Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res. 509: 119-124. (Pubitemid 20043627)
33. Saura, J., J. M. Tusell, and J. Serratosa. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44: 183-189. (Pubitemid 37484470)
34. Ohgami, N., R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama. 2001. CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products. J. Biol. Chem. 276: 3195-3202. (Pubitemid 37411612)
35. Knauer, M. F., B. Soreghan, D. Burdick, J. Kosmoski, and C. G. Glabe. 1992. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/β protein. Proc. Natl. Acad. Sci. USA 89: 7437-7441.
36. Kuwabara, Y., A. Yokoyama, L. Yang, K. Toku, K. Mori, I. Takeda, T. Shigekawa, B. Zhang, N. Maeda, M. Sakanaka, and J. Tanaka. 2003. Two populations of microglial cells isolated from rat primary mixed glial cultures. J. Neurosci. Res. 73: 22-30. (Pubitemid 36791367)
37. Coraci, I. S., J. Husemann, J. W. Berman, C. Hulette, J. H. Dufour, G. K. Campanella, A. D. Luster, S. C. Silverstein, and J. B. El-Khoury. 2002. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils. Am. J. Pathol. 160: 101-112.
38. Deane, R., S. Du Yan, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, et al. 2003. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9: 907-913. (Pubitemid 36889934)
39. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106: 1489-1499.
40. Mitrasinovic, O. M., and G. M. Murphy, Jr. 2002. Accelerated phagocytosis of amyloid-β by mouse and human microglia overexpressing the macrophage colony-stimulating factor receptor. J. Biol. Chem. 277: 29889-29896.
41. Iwata, N., S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N. P. Gerard, C. Gerard, E. Hama, H. J. Lee, and T. C. Saido. 2001. Metabolic regulation of brain Aβ by neprilysin. Science 292: 1550-1552.
42. Qiu, W. Q., D. M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M. B. Podlisny, M. R. Rosner, A. Safavi, L. B. Hersh, and D. J. Selkoe. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem. 273: 32730-32738.
43. Kanemitsu, H., T. Tomiyama, and H. Mori. 2003. Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci. Lett. 350: 113-116. (Pubitemid 37101425)
44. Farris, W., S. Mansourian, Y. Chang, L. Lindsley, E. A. Eckman, M. P. Frosch, C. B. Eckman, R. E. Tanzi, D. J. Selkoe, and S. Guenette. 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. USA 100: 4162-4167. (Pubitemid 36418174)
45. Sawada, M., K. Imamura, and T. Nagatsu. 2006. Role of cytokines in inflammatory process in Parkinson's disease. J. Neural. Transm. 70(Suppl.): 373-381. (Pubitemid 44622226)
46. Suzumura, A., M. Sawada, Y. Itoh, and T. Marunouchi. 1994. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J. Neuroimmunol. 53: 209-218. (Pubitemid 24272012)
47. Chao, C. C., T. W. Molitor, and S. Hu. 1993. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151: 1473-1481.
48. Abbas, N., I. Bednar, E. Mix, S. Marie, D. Paterson, A. Ljungberg, C. Morris, B. Winblad, A. Nordberg, and J. Zhu. 2002. Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice. J. Neuroimmunol. 126: 50-55. (Pubitemid 34521731)
49. Nolan, Y., F. O. Maher, D. S. Martin, R. M. Clarke, M. T. Brady, A. E. Bolton, K. H. Mills, and M. A. Lynch. 2005. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. J. Biol. Chem. 280: 9354-9362. (Pubitemid 40409629)
50. Hickey, W. F., B. L. Hsu, and H. Kimura. 1991. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254-260.
51. Rogers, J., J. Luber-Narod, S. D. Styren, and W. H. Civin. 1988. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9: 339-349. (Pubitemid 19262065)
52. Togo, T., H. Akiyama, E. Iseki, H. Kondo, K. Ikeda, M. Kato, T. Oda, K. Tsuchiya, and K. Kosaka. 2002. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124: 83-92. (Pubitemid 34212013)
53. Archambault, A. S., J. Sim, M. A. Gimenez, and J. H. Russell. 2005. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur. J. Immunol. 35: 1076-1085.
54. Town, T., J. Tan, R. A. Flavell, and M. Mullan. 2005. T-cells in Alzheimer's disease. Neuromolecular Med. 7: 255-264.
55. Abbott, N. J. 2000. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell. Mol. Neurobiol. 20: 131-147. (Pubitemid 30091452)
56. Berzin, T. M., B. D. Zipser, M. S. Rafii, V. Kuo-Leblanc, G. D. Yancopoulos, D. J. Glass, J. R. Fallon, and E. G. Stopa. 2000. Agrin and microvascular damage in Alzheimer's disease. Neurobiol. Aging 21: 349-355. (Pubitemid 30387094)
57. Monsonego, A., J. Imitola, V. Zota, T. Oida, and H. L. Weiner. 2003. Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid β-peptide presentation to Th1 cells. J. Immunol. 171: 2216-2224. (Pubitemid 37025526)
58. Nicoll, J. A., D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R. O. Weller. 2003. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med. 9: 448-452.
59. Akiyama, H., and P. L. McGeer. 2004. Specificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease. Nat. Med. 10: 117-118.
60. Steinke, J. W., and L. Borish. 2001. Th2 cytokines and asthma: interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2: 66-70.
61. Rand, R. W., R. J. Kreitman, N. Patronas, F. Varricchio, I. Pastan, and R. K. Puri. 2000. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin. Cancer Res. 6: 2157-2165.
62. Weiner, H. L., C. A. Lemere, R. Maron, E. T. Spooner, T. J. Grenfell, C. Mori, S. Issazadeh, W. W. Hancock, and D. J. Selkoe. 2000. Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 48: 567-579.